[1]
B. C. Edina and I. Rinaldi, “Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin’s Lymphoma or Mantle-Cell Lymphoma”, Acta Med Indones, vol. 54, no. 2, p. 316, Jul. 2022.